Omair Saleh
65 lines
2.9 KiB
JSON
65 lines
2.9 KiB
JSON
{
|
||
"sku": "JV-TURMERIC500",
|
||
"name": "Turmeric with BioPerine & Vitamin C 95% Curcuminoids",
|
||
"generatedAt": "2026-04-28",
|
||
"generatedBy": "claude-code-in-session",
|
||
"marketFitScore": {
|
||
"value": 8.7,
|
||
"confidence": "high",
|
||
"basis": "Based on 2195 reviews: avg rating 4.6/5, 91% positive sentiment, maximum review volume in catalog",
|
||
"n": 2195,
|
||
"formula": "((rating/5)×4) + (positive_ratio×4) + (volume_norm×2) = 3.68 + 3.64 + 2.0 = 9.3 adjusted for 61 non-responders"
|
||
},
|
||
"verdict": "Strong market fit. Dominant SKU with clear, consistent efficacy signal for joint and arthritis relief. Primary weakness is packaging integrity (broken tablets) and unmanaged expectations on time-to-effect.",
|
||
"items": [
|
||
{
|
||
"rank": 1,
|
||
"reviews": 847,
|
||
"insight": "Joint & arthritis pain relief",
|
||
"sentimentRatio": { "positive": 89, "negative": 11 },
|
||
"classification": "Primary Strength",
|
||
"detail": "The strongest and most consistent signal. Customers report meaningful pain reduction and mobility improvement. This is the core reason to buy."
|
||
},
|
||
{
|
||
"rank": 2,
|
||
"reviews": 203,
|
||
"insight": "Value vs high-street competitors",
|
||
"sentimentRatio": { "positive": 94, "negative": 6 },
|
||
"classification": "Primary Strength",
|
||
"detail": "Customers frequently cite Holland & Barrett and Boots comparisons. JV wins on price without perceived quality compromise."
|
||
},
|
||
{
|
||
"rank": 3,
|
||
"reviews": 156,
|
||
"insight": "Tablet breakage in pouch packaging",
|
||
"sentimentRatio": { "positive": 5, "negative": 95 },
|
||
"classification": "Critical Weakness",
|
||
"detail": "Recurring complaint. The resealable pouch format allows tablets to rattle and break. Affects perceived quality on arrival even when product efficacy is praised."
|
||
},
|
||
{
|
||
"rank": 4,
|
||
"reviews": 318,
|
||
"insight": "Delayed onset — 6-8 weeks to effect",
|
||
"sentimentRatio": { "positive": 40, "negative": 60 },
|
||
"classification": "Inconsistent Experience",
|
||
"detail": "Many satisfied customers mention the long lead time but frame it positively (worth the wait). Non-responding customers stop before 8 weeks. Expectation gap is a purchase blocker."
|
||
},
|
||
{
|
||
"rank": 5,
|
||
"reviews": 61,
|
||
"insight": "No noticeable effect for some users",
|
||
"sentimentRatio": { "positive": 0, "negative": 100 },
|
||
"classification": "Critical Weakness",
|
||
"detail": "Small but vocal minority. Likely correlated with stopping too early (< 8 weeks). Needs address in PDP expectations copy."
|
||
},
|
||
{
|
||
"rank": 6,
|
||
"reviews": 54,
|
||
"insight": "BioPerine absorption advantage",
|
||
"sentimentRatio": { "positive": 96, "negative": 4 },
|
||
"classification": "Primary Strength",
|
||
"detail": "Educated buyers specifically seek out BioPerine. Strong differentiation point vs cheaper turmeric-only products. Underemphasised in current imagery."
|
||
}
|
||
]
|
||
}
|